Annual Meeting of the Japanese Society of Toxicology
The 48th Annual Meeting of the Japanese Society of Toxicology
Session ID : W6-2
Conference information

Workshop 6
Adverse effects associated with Chemotherapy (pediatric osteosarcoma)
*Shigehito TAKESHITA
Author information
CONFERENCE PROCEEDINGS FREE ACCESS

Details
Abstract

The incidence of osteosarcoma is ca. 1-1.5/year/million in Japan. Osteosarcoma is more likely to occur in children and teens aged 10-20 years. Chemotherapy before and after tumor resection has become standard of care with an overall treatment duration of 1 year. However, chemotherapy often causes serious side effects including hair loss, vomitus, and leukopenia.

In this presentation, my experience of anticancer drug treatment to my family; especially adverse reactions and also its supportive care during the 8-month neoadjuvant and 5-month postoperative chemotherapies will be introduced.

Content from these authors
© 2021 The Japanese Society of Toxicology
Previous article Next article
feedback
Top